Atlas Trials

Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg

Clinical trial NCT02789150 · COMPLETED

Trial details

NCT number
NCT02789150
Sponsor
University of Louisville
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Hepatorenal Syndrome
Start date
2015-01-01
Primary completion
2018-01-11
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.